Primary immunodeficiencies (PIDs) are heterogeneous disorders, characterized by variable clinical and immunological features. National PID registries offer useful insights on the epidemiology, diagnosis, and natural history of these disorders. In 1999, the Italian network for primary immunodeficiencies (IPINet) was established. We report on data collected from the IPINet registry after 20 years of activity. A total of 3352 pediatric and adult patients affected with PIDs are registered in the database. In Italy, a regional distribution trend of PID diagnosis was observed. Based on the updated IUIS classification of 2019, PID distribution in Italy showed that predominantly antibody deficiencies account for the majority of cases (63%), followed by combined immunodeficiencies with associated or syndromic features (22.5%). The overall age at diagnosis was younger for male patients. The minimal prevalence of PIDs in Italy resulted in 5.1 per 100.000 habitants. Mortality was similar to other European registries (4.2%). Immunoglobulin replacement treatment was prescribed to less than one third of the patient cohort. Collectively, this is the first comprehensive description of the PID epidemiology in Italy.

The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) / Lougaris, V.; Pession, A.; Baronio, M.; Soresina, A.; Rondelli, R.; Gazzurelli, L.; Benvenuto, A.; Martino, S.; Gattorno, M.; Biondi, A.; Zecca, M.; Marinoni, M.; Fabio, G.; Aiuti, A.; Marseglia, G.; Putti, M. C.; Agostini, C.; Lunardi, C.; Tommasini, A.; Bertolini, P.; Gambineri, E.; Consolini, R.; Matucci, A.; Azzari, C.; Danieli, M. G.; Paganelli, R.; Duse, M.; Cancrini, C.; Moschese, V.; Chessa, L.; Spadaro, G.; Civino, A.; Vacca, A.; Cardinale, F.; Martire, B.; Carpino, L.; Trizzino, A.; Russo, G.; Cossu, F.; Badolato, R.; Pietrogrande, M. C.; Quinti, I.; Rossi, P.; Ugazio, A.; Pignata, C.; Plebani, A.. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 0271-9142. - 40:7(2020), pp. 1026-1037. [10.1007/s10875-020-00844-0]

The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

Pession A.;Benvenuto A.;Marseglia G.;Duse M.;Moschese V.;Spadaro G.;Martire B.;Badolato R.;Pietrogrande M. C.;Pignata C.;
2020

Abstract

Primary immunodeficiencies (PIDs) are heterogeneous disorders, characterized by variable clinical and immunological features. National PID registries offer useful insights on the epidemiology, diagnosis, and natural history of these disorders. In 1999, the Italian network for primary immunodeficiencies (IPINet) was established. We report on data collected from the IPINet registry after 20 years of activity. A total of 3352 pediatric and adult patients affected with PIDs are registered in the database. In Italy, a regional distribution trend of PID diagnosis was observed. Based on the updated IUIS classification of 2019, PID distribution in Italy showed that predominantly antibody deficiencies account for the majority of cases (63%), followed by combined immunodeficiencies with associated or syndromic features (22.5%). The overall age at diagnosis was younger for male patients. The minimal prevalence of PIDs in Italy resulted in 5.1 per 100.000 habitants. Mortality was similar to other European registries (4.2%). Immunoglobulin replacement treatment was prescribed to less than one third of the patient cohort. Collectively, this is the first comprehensive description of the PID epidemiology in Italy.
2020
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) / Lougaris, V.; Pession, A.; Baronio, M.; Soresina, A.; Rondelli, R.; Gazzurelli, L.; Benvenuto, A.; Martino, S.; Gattorno, M.; Biondi, A.; Zecca, M.; Marinoni, M.; Fabio, G.; Aiuti, A.; Marseglia, G.; Putti, M. C.; Agostini, C.; Lunardi, C.; Tommasini, A.; Bertolini, P.; Gambineri, E.; Consolini, R.; Matucci, A.; Azzari, C.; Danieli, M. G.; Paganelli, R.; Duse, M.; Cancrini, C.; Moschese, V.; Chessa, L.; Spadaro, G.; Civino, A.; Vacca, A.; Cardinale, F.; Martire, B.; Carpino, L.; Trizzino, A.; Russo, G.; Cossu, F.; Badolato, R.; Pietrogrande, M. C.; Quinti, I.; Rossi, P.; Ugazio, A.; Pignata, C.; Plebani, A.. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 0271-9142. - 40:7(2020), pp. 1026-1037. [10.1007/s10875-020-00844-0]
File in questo prodotto:
File Dimensione Formato  
10875_2020_Article_844.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 1.21 MB
Formato Adobe PDF
1.21 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/828788
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact